Single photon emission computed tomography for the diagnosis of coronary artery disease: An evidence-based analysis

Ontario Health Technology Assessment Series

Volumn 10, Issue 8, 2010, Pages 1-64

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201;

ANGIOCARDIOGRAPHY; CANADA; CLINICAL RESEARCH; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; EXERCISE TEST; HALF LIFE TIME; HEALTH CARE COST; HEART SCINTISCANNING; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; MEDICAL LITERATURE; NON INVASIVE MEASUREMENT; PATIENT SAFETY; PUBLICATION; RADIATION DOSE; REVIEW; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 77953863688     PISSN: 19157398     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (139)

1. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. Endorsed by the American College of Emergency Physicians. J Am Coll Cardiol 2009; 53(23):2201-29.
2. Mowatt G, Vale L, Brazzelli M, Hernandez R, Murray A, Scott N et al. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Health Technol Assess 2004; 8(30):1-223.
3. National Health Service. Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction [Internet]. [updated 2003; cited 2009 Oct 29]. Available from: http://www.nice.org.uk/TA73
4. Gibbons RJ. Myocardial perfusion imaging. Heart 2000; 83(3):355-60.
5. Canadian Cancer Society. Medical isotopes shortage [Internet]. [updated 2009 Dec 13; cited 2009 Dec 14]. Available from: http://www.cancer.ca/Canada- wide/About%20us/Media%20centre/Issues%20watch/Medical%20isotope%20shortage.aspx? sc-lang=en
6. Atomic Energy of Canada Limited. NRU Status Report #35 - AECL provides update on NRU activities [Internet]. [updated 2009 Dec 23; cited 2009 Dec 18]. Available from: http://www.aecl.ca/NewsRoom/Community-Bulletins/091223.htm
7. Ministry of Health and Long-Term Care. Guidelines for the prioritization of procedures employing Tc-99m [Internet]. [updated 2009 May; cited 2009 Dec 18]. Available from: http://www.health.gov.on.ca/english/providers/program/emu/ health-notices/ihn-guidelines-20090520.pdf
8. Baghdasarian SB, Heller GV. The role of myocardial perfusion imaging in the diagnosis of patients with coronary artery disease: developments over the past year. Curr Opin Cardiol 2005; 20(5):369-74.
9. Heller GV, Links J, Bateman TM, Ziffer JA, Ficaro E, Cohen MC et al. American Society of Nuclear Cardiology and Society of Nuclear Medicine joint position statement: Attenuation correction of myocardial perfusion SPECT scintigraphy. J Nucl Cardiol 2004; 11(2):229-30. (Pubitemid 38949918)
10. Garcia EV. SPECT attenuation correction: an essential tool to realize nuclear cardiology's manifest destiny. J Nucl Cardiol 2007; 14(1):16-24.
11. Garcia EV. Quantitative myocardial perfusion single-photon emission computed tomographic imaging: quo vadis? (Where do we go from here?). J Nucl Cardiol 1994; 1(1):83-93.
12. Chu H, Cole SR. Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol 2006; 59(12):1331-2. (Pubitemid 44708615)
13. Benjamini Y, Hochburg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57(1):289-300.
14. Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336(7653):1106-10. (Pubitemid 351731739)
15. Heijenbrok-Kal MH, Fleischmann KE, Hunink MG. Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J 2007; 154(3):415-23.
16. O'Keefe JH, Jr., Barnhart CS, Bateman TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol 1995; 75(11):25D-34D.
17. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998; 280(10):913-20.
18. Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis. Am Heart J 2001; 142(6):934-44. (Pubitemid 33131799)
19. Imran MB, Palinkas A, Picano E. Head-to-head comparison of dipyridamole echocardiography and stress perfusion scintigraphy for the detection of coronary artery disease: a meta-analysis. Comparison between stress echo and scintigraphy. The International Journal of Cardiovascular Imaging 2003; 19(1):23-8. (Pubitemid 36167988)
20. Daou D, Delahaye N, Vilain D, Lebtahi R, Faraggi M, Le GD. Identification of extensive coronary artery disease: incremental value of exercise Tl-201 SPECT to clinical and stress test variables. J Nucl Cardiol 2002; 9(2):161-8.
21. De S, Searles G, Haddad H. The prevalence of cardiac risk factors in women 45 years of age or younger undergoing angiography for evaluation of undiagnosed chest pain. Can J Cardiol 2002; 18(9):945-8.
22. Gentile R, Vitarelli A, Schillaci O, Lagana B, Gianni C, Rossi-Fanelli F et al. Diagnostic accuracy and prognostic implications of stress testing for coronary artery disease in the elderly. Ital Heart J 2001; 2(7):539-45. (Pubitemid 32780765)
23. Kajinami K, Seki H, Takekoshi N, Mabuchi H. Noninvasive prediction of coronary atherosclerosis by quantification of coronary artery calcification using electron beam computed tomography: comparison with electrocardiographic and thallium exercise stress test results. J Am Coll Cardiol 1995; 26(5):1209-21.
24. Khattar RS, Senior R, Lahiri A. Assessment of myocardial perfusion and contractile function by inotropic stress Tc-99m sestamibi SPECT imaging and echocardiography for optimal detection of multivessel coronary artery disease. Heart 1998; 79(3):274-80. (Pubitemid 28212217)
25. McClellan JR, Dugan TM, Heller GV. Patterns of use and clinical utility of exercise thallium-201 single photon emission-computed tomography in a community hospital. Cardiology 1996; 87(2):134-40.
26. Michaelides AP, Psomadaki ZD, Dilaveris PE, Richter DJ, Andrikopoulos GK, Aggeli KD et al. Improved detection of coronary artery disease by exercise electrocardiography with the use of right precordial leads. N Engl J Med 1999; 340(5):340-5.
27. Nallamothu N, Ghods M, Heo J, Iskandrian AS. Comparison of thallium-201 single-photon emission computed tomography and electrocardiographic response during exercise in patients with normal rest electrocardiographic results. J Am Coll Cardiol 1995; 25(4):830-6.
28. Psirropoulos D, Efthimiadis A, Boudonas G, Papadopoulos I, Papadopoulos G, Ekklisiarchos D et al. Detection of myocardial ischemia in the elderly versus the young by stress thallium-201 scintigraphy and its relation to important coronary artery disease. Heart Vessels 2002; 16(4):131-6. (Pubitemid 34552510)
29. Shirai N, Yamagishi H, Yoshiyama M, Teragaki M, Akioka K, Takeuchi K et al. Incremental value of assessment of regional wall motion for detection of multivessel coronary artery disease in exercise (201)Tl gated myocardial perfusion imaging. J Nucl Med 2002; 43(4):443-50.
30. Santana-Boado C, Candell-Riera J, Castell-Conesa J, guade-Bruix S, Garcia-Burillo A, Canela T et al. Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med 1998; 39(5):751-5.
31. Gallowitsch HJ, Sykora J, Mikosch P, Kresnik E, Unterweger O, Molnar M et al. Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities. Eur J Nucl Med 1998; 25(3):220-8. (Pubitemid 28181720)
32. Heiba SI, Hayat NJ, Salman HS, Higazy E, Sayed ME, Saleh Z et al. Technetium-99m-MIBI myocardial SPECT: supine versus right lateral imaging and comparison with coronary arteriography. J Nucl Med 1997; 38(10):1510-4. (Pubitemid 27443947)
33. Palmas W, Friedman JD, Diamond GA, Silber H, Kiat H, Berman DS. Incremental value of simultaneous assessment of myocardial function and perfusion with technetium-99m sestamibi for prediction of extent of coronary artery disease. J Am Coll Cardiol 1995; 25(5):1024-31.
34. Rubello D, Zanco P, Candelpergher G, Borsato N, Chierichetti F, Saitta B et al. Usefulness of 99mTc-MIBI stress myocardial SPECT bull's-eye quantification in coronary artery disease. Q J Nucl Med 1995; 39(2):111-5.
35. Taillefer R, Depuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29(1):69-77.
36. Amanullah AM, Berman DS, Kiat H, Friedman JD. Usefulness of hemodynamic changes during adenosine infusion in predicting the diagnostic accuracy of adenosine technetium-99m sestamibi single-photon emission computed tomography (SPECT). Am J Cardiol 1997; 79(10):1319-22.
37. Di B, V, Bellina CR, Gori E, Molea N, Talarico L, Boni G et al. Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery disease. J Nucl Cardiol 1996; 3(3):212-20.
38. Elhendy A, Van Domburg RT, Bax JJ, Nierop PR, Geleijnse ML, Ibrahim MM et al. Noninvasive diagnosis of coronary artery stenosis in women with limited exercise capacity: comparison of dobutamine stress echocardiography and 99mTc sestamibi single-photon emission CT. Chest 1998; 114(4):1097-104.
39. Ho FM, Huang PJ, Liau CS, Lee FK, Chieng PU, Su CT et al. Dobutamine stress echocardiography compared with dipyridamole thallium-201 single-photon emission computed tomography in detecting coronary artery disease. Eur Heart J 1995; 16(4):570-5.
40. Ho YL, Wu CC, Huang PJ, Tseng WK, Lin LC, Chieng PU et al. Dobutamine stress echocardiography compared with exercise thallium-201 single-photon emission computed tomography in detecting coronary artery disease-effect of exercise level on accuracy. Cardiology 1997; 88(4):379-85.
41. Huang PJ, Yen RF, Chieng PU, Chen ML, Su CT. Do beta-blockers affect the diagnostic sensitivity of dobutamine stress thallium-201 single photon emission computed tomographic imaging? J Nucl Cardiol 1998; 5(1):34-9.
42. Huang PJ, Ho YL, Wu CC, Chao CL, Chen MF, Chieng PU et al. Simultaneous dobutamine stress echocardiography and thallium-201 perfusion imaging for the detection of coronary artery disease. Cardiology 1997; 88(6):556-62.
43. Miller DD, Younis LT, Chaitman BR, Stratmann H. Diagnostic accuracy of dipyridamole technetium 99m-labeled sestamibi myocardial tomography for detection of coronary artery disease. J Nucl Cardiol 1997; 4(1 Pt 1):18-24.
44. Mohiuddin SM, Ravage CK, Esterbrooks DJ, Lucas BD, Jr., Hilleman DE. The comparative safety and diagnostic accuracy of adenosine myocardial perfusion imaging in women versus men. Pharmacotherapy 1996; 16(4):646-51.
45. San Roman JA, Vilacosta I, Castillo JA, Rollan MJ, Hernandez M, Peral V et al. Selection of the optimal stress test for the diagnosis of coronary artery disease. Heart 1998; 80(4):370-6. (Pubitemid 28470770)
46. Santoro GM, Sciagra R, Buonamici P, Consoli N, Mazzoni V, Zerauschek F et al. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without history of coronary artery disease. J Nucl Cardiol 1998; 5(1):19-27. (Pubitemid 28084962)
47. Schillaci O, Moroni C, Scopinaro F, Tavolaro R, Danieli R, Bossini A et al. Technetium-99m sestamibi myocardial tomography based on dipyridamole echocardiography testing in hypertensive patients with chest pain. Eur J Nucl Med 1997; 24(7):774-8. (Pubitemid 27356857)
48. Slavich GA, Guerra UP, Morocutti G, Fioretti PM, Fresco C, Orlandi C et al. Feasibility of simultaneous Tc99m sestamibi and 2D-echo cardiac imaging during dobutamine pharmacologic stress. Preliminary results in a female population. Int J Card Imaging 1996; 12(2):113-8.
49. Soman P, Khattar R, Senior R, Lahiri A. Inotropic stress with arbutamine is superior to vasodilator stress with dipyridamole for the detection of reversible ischemia with Tc-99m sestamibi single-photon emission computed tomography. J Nucl Cardiol 1997; 4(5):364-71. (Pubitemid 27491447)
50. Takeuchi M, Sonoda S, Miura Y, Kuroiwa A. Comparative diagnostic value of dobutamine stress echocardiography and stress thallium-201 single-photon- emission computed tomography for detecting coronary artery disease in women. Coron Artery Dis 1996; 7(11):831-5. (Pubitemid 27020356)
51. Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Kinoshita M, Kumano S. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy. J Nucl Med 1997; 38(4):577-81. (Pubitemid 27163652)
52. Fragasso G, Lu C, Dabrowski P, Pagnotta P, Sheiban I, Chierchia SL. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol 1999; 34(2):441-7.
53. Astarita C, Palinkas A, Nicolai E, Maresca FS, Varga A, Picano E. Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test. J Hypertens 2001; 19(3):495-502. (Pubitemid 32195386)
54. Cramer MJ, van der Wall EE, Jaarsma W, Verzijlbergen JF, Niemeyer MG, Zwinderman AH et al. Detection of coronary artery disease: comparison between technetium 99m-labeled sestamibi single-photon emission computed tomography and two-dimensional echocardiography with dipyridamole low-level exercise-stress. J Nucl Cardiol 1996; 3(5):389-94. (Pubitemid 26373447)
55. Ogilby JD, Kegel JG, Heo J, Iskandrian AE. Correlation between hemodynamic changes and tomographic sestamibi imaging during dipyridamole-induced coronary hyperemia. J Am Coll Cardiol 1998; 31(1):75-82.
56. Ficaro EP, Fessler JA, Shreve PD, Kritzman JN, Rose PA, Corbett JR. Simultaneous transmission/emission myocardial perfusion tomography. Diagnostic accuracy of attenuation-corrected 99mTc-sestamibi single-photon emission computed tomography. Circulation 1996; 93(3):463-73.
57. Iftikhar I, Koutelou M, Mahmarian JJ, Verani MS. Simultaneous perfusion tomography and radionuclide angiography during dobutamine stress. J Nucl Med 1996; 37(8):1306-10.
58. Kisacik HL, Ozdemir K, Altinyay E, Oguzhan A, Kural T, Kir M et al. Comparison of exercise stress testing with simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computerized tomography for diagnosis of coronary artery disease. Eur Heart J 1996; 17(1):113-9.
59. Benoit T, Vivegnis D, Lahiri A, Itti R, Braat S, Rigo P. Tomographic myocardial imaging with technetium-99m tetrofosmin. Comparison with tetrofosmin and thallium planar imaging and with angiography. Eur Heart J 1996; 17(4):635-42.
60. Links JM, Becker LC, Rigo P, Taillefer R, Hanelin L, Anstett F et al. Combined corrections for attenuation, depth-dependent blur, and motion in cardiac SPECT: a multicenter trial. J Nucl Cardiol 2000; 7(5):414-25.
61. Emmett L, Iwanochko RM, Freeman MR, Barolet A, Lee DS, Husain M. Reversible regional wall motion abnormalities on exercise technetium-99m-gated cardiac single photon emission computed tomography predict high-grade angiographic stenoses. J Am Coll Cardiol 2002; 39(6):991-8.
62. He Q, Yao Z, Yu X, Qu W, Sun F, Ji F et al. Evaluation of 99mTc-MIBI myocardial perfusion imaging with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. Chin Med J (Engl) 2002; 115(11):1603-7.
63. He ZX, Shi RF, Wu YJ, Tian YQ, Liu XJ, Wang SW et al. Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease.[see comment]. Circulation 2003; 108(10):1208-13.
64. Lima RS, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol 2003; 42(1):64-70.
65. Rollan MJ, San Roman JA, Vilacosta I, Ramon OJ, Bratos JL. Dobutamine stress echocardiography in the diagnosis of coronary artery disease in women with chest pain: Comparison with different noninvasive tests. Clin Cardiol 2002; 25(12):559-64. (Pubitemid 35424144)
66. Tsai M-F, Kao P-F, Tzen K-Y. Improved diagnostic performance of thallium-201 myocardial perfusion scintigraphy in coronary artery disease: From planar to single photon emission computed tomography imaging. Chang Gung Medical Journal 2002; 25(8):522-30.
67. Groutars RGEJ, Verzijlbergen JF, Tiel-Van Buul MMC, Zwinderman AH, Ascoop CAPL, van Hemel NM et al. The accuracy of 1-day dual-isotope myocardial SPECT in a population with high prevalence of coronary artery disease. Int J Cardiovasc Imaging 2003; 19(3):229-38.
68. Hannoush H, Shaar K, Alam S, Nasrallah A, Sawaya J, Dakik HA. Analysis of referral patterns, predictive accuracy, and impact on patient management of myocardial perfusion imaging in a new nuclear cardiology laboratory. J Nucl Cardiol 2003; 10(2):148-53. (Pubitemid 36503800)
69. Shelley S, Sathyamurthy I, Madhavan, Subramanyan K, Najeeb OM, Ramachandran P. Adenosine myocardial SPECT- its efficacy and safety and correlation with coronary angiogram. J Assoc Physicians India 2003; 51:557-60. (Pubitemid 41279919)
70. Dondi M, Fagioli G, Salgarello M, Zoboli S, Nanni C, Cidda C. Myocardial SPECT: what do we gain from attenuation correction (and when)? Q J Nucl Med Mol Imaging 2004; 48(3):181-7.
71. Grossman GB, Garcia EV, Bateman TM, Heller GV, Johnson LL, Folks RD et al. Quantitative Tc-99m sestamibi attenuation-corrected SPECT: development and multicenter trial validation of myocardial perfusion stress gender-independent normal database in an obese population. J Nucl Cardiol 2004; 11(3):263-72.
72. Hambye AS, Vervaet AM, Dobbeleir AA. Head-to-head comparison of uncorrected and scatter corrected, summed and end diastolic myocardial perfusion SPECT in coronary artery disease. Nucl Med Commun 2004; 25(4):347-53.
73. Patsilinakos SP, Spanodimos S, Rontoyanni F, Kranidis A, Antonelis IP, Sotirellos K et al. Adenosine stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. J Nucl Cardiol 2004; 11(1):20-5. (Pubitemid 38219565)
74. Peltier M, Vancraeynest D, Pasquet A, Ay T, Roelants V, D'Hondt AM et al. Assessment of the physiologic significance of coronary disease with dipyridamole real-time myocardial contrast echocardiography. Comparison with technetium-99m sestamibi single-photon emission computed tomography and quantitative coronary angiography. J Am Coll Cardiol 2004; 43(2):257-64.
75. Senior R, Lepper W, Pasquet A, Chung G, Hoffman R, Vanoverschelde JL et al. Myocardial perfusion assessment in patients with medium probability of coronary artery disease and no prior myocardial infarction: comparison of myocardial contrast echocardiography with 99mTc single-photon emission computed tomography. Am Heart J 2004; 147(6):1100-5. (Pubitemid 38880971)
76. Yao ZM, Li W, Qu WY, Zhou C, He Q, Ji FS. Comparison of (99)mTc-methoxyisobutylisonitrile myocardial single-photon emission computed tomography and electron beam computed tomography for detecting coronary artery disease in patients with no myocardial infarction. Chin Med J (Engl) 2004; 117(5):700-5.
77. Gonzalez P, Massardo T, Jofre MJ, Yovanovich J, Prat H, Munoz A et al. 201Tl myocardial SPECT detects significant coronary artery disease between 50% and 75% angiogram stenosis. Rev Esp Med Nucl 2005; 24(5):305-11. (Pubitemid 41726085)
78. Johansen A, Hoilund-Carlsen PF, Christensen HW, Vach W, Jorgensen HB, Veje A et al. Diagnostic accuracy of myocardial perfusion imaging in a study population without post-test referral bias. J Nucl Cardiol 2005; 12(5):530-7. (Pubitemid 41364054)
79. Masood Y, Liu YH, DePuey G, Taillefer R, Araujo LI, Allen S et al. Clinical validation of SPECT attenuation correction using x-ray computed tomography-derived attenuation maps: multicenter clinical trial with angiographic correlation. J Nucl Cardiol 2005; 12(6):676-86. (Pubitemid 43033608)
80. Sakuma H, Suzawa N, Ichikawa Y, Makino K, Hirano T, Kitagawa K et al. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am J Roentgenol 2005; 185(1):95-102.
81. Thompson RC, Heller GV, Johnson LL, Case JA, Cullom SJ, Garcia EV et al. Value of attenuation correction on ECG-gated SPECT myocardial perfusion imaging related to body mass index. J Nucl Cardiol 2005; 12(2):195-202.
82. Berman DS, Kang X, Nishina H, Slomka PJ, Shaw LJ, Hayes SW et al. Diagnostic accuracy of gated Tc-99m sestamibi stress myocardial perfusion SPECT with combined supine and prone acquisitions to detect coronary artery disease in obese and nonobese patients. J Nucl Cardiol 2006; 13(2):191-201.
83. Elhendy A, Schinkel AFL, Bax JJ, Van Domburg RT, Valkema R, Biagini E et al. Accuracy of stress Tc-99m tetrofosmin myocardial perfusion tomography for the diagnosis and localization of coronary artery disease in women. J Nucl Cardiol 2006; 13(5):629-34.
84. Hung GU, Lee KW, Chen CP, Yang KT, Lin WY. Worsening of left ventricular ejection fraction induced by dipyridamole on Tl-201 gated myocardial perfusion imaging predicts significant coronary artery disease. J Nucl Cardiol 2006; 13(2):225-32.
85. Jeetley P, Hickman M, Kamp O, Lang RM, Thomas JD, Vannan MA et al. Myocardial contrast echocardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol 2006; 47(1):141-5.
86. Korosoglou G, Dubart AE, DaSilva KG, Jr., Labadze N, Hardt S, Hansen A et al. Real-time myocardial perfusion imaging for pharmacologic stress testing: added value to single photon emission computed tomography. Am Heart J 2006; 151(1):131-8.
87. Lin SL, Chiou KR, Huang WC, Peng NJ, Tsay DG, Liu CP. Detection of coronary artery disease using real-time myocardial contrast echocardiography: a comparison with dual-isotope resting thallium-201/stress technectium-99m sestamibi single-photon emission computed tomography. Heart and Vessels 2006; 21(4):226-35.
88. Matsumoto N, Sato Y, Suzuki Y, Yoda S, Kunimasa T, Kato M et al. Usefulness of rapid low-dose/high-dose 1-day 99mTc-sestamibi ECG-gated myocardial perfusion single-photon emission computed tomography. Circ J 2006; 70(12):1585-9.
89. Slomka PJ, Fish MB, Lorenzo S, Nishina H, Gerlach J, Berman DS et al. Simplified normal limits and automated quantitative assessment for attenuation-corrected myocardial perfusion SPECT. J Nucl Cardiol 2006; 13(5):642-51.
90. Aggeli C, Christoforatou E, Giannopoulos G, Roussakis G, Kokkinakis C, Barbetseas J et al. The diagnostic value of adenosine stress-contrast echocardiography for diagnosis of coronary artery disease in hypertensive patients: comparison to Tl-201 single-photon emission computed tomography. Am J Hypertens 2007; 20(5):533-8.
91. Banzo I, Pena FJ, Allende RH, Quirce R, Carril JM. Prospective clinical comparison of non-corrected and attenuation- and scatter-corrected myocardial perfusion SPECT in patients with suspicion of coronary artery disease. Nucl Med Commun 2003; 24(9):995-1002.
92. Mieres JH, Makaryus AN, Cacciabaudo JM, Donaldson D, Green SJ, Heller GV et al. Value of electrocardiographically gated single-photon emission computed tomographic myocardial perfusion scintigraphy in a cohort of symptomatic postmenopausal women. Am J Cardiol 2007; 99(8):1096-9. (Pubitemid 46560464)
93. Schepis T, Gaemperli O, Koepfli P, Namdar M, Valenta I, Scheffel H et al. Added value of coronary artery calcium score as an adjunct to gated SPECT for the evaluation of coronary artery disease in an intermediate-risk population. J Nucl Med 2007; 48(9):1424-30. (Pubitemid 47397389)
94. Yeih DF, Huang PJ, Ho YL. Enhanced diagnosis of coronary artery disease in women by dobutamine thallium-201 ST-segment/heart rate slope and thallium-201 myocardial SPECT. J Formos Med Assoc 2007; 106(10):832-9.
95. Bokhari S, Shahzad A, Bergmann SR. Superiority of exercise myocardial perfusion imaging compared with the exercise ECG in the diagnosis of coronary artery disease. Coron Artery Dis 2008; 19(6):399-404.
96. Katayama T, Ogata N, Tsuruya Y. Diagnostic accuracy of supine and prone thallium-201 stress myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in inferior wall of left ventricle. Ann Nucl Med 2008; 22(4):317-21. (Pubitemid 351809799)
97. Lipiec P, Wejner-mik P, Krzeminska-pakula M, Kusmierek J, Plachcinska A, Szuminski R et al. Accelerated stress real-time myocardial contrast echocardiography for the detection of coronary artery disease: comparison with 99mTc single photon emission computed tomography. J Am Soc Echocardiogr 2008; 21(8):941-7.
98. Suzuki Y, Slomka PJ, Wolak A, Ohba M, Suzuki S, De YL et al. Motion-frozen myocardial perfusion SPECT improves detection of coronary artery disease in obese patients. J Nucl Med 2008; 49(7):1075-9. (Pubitemid 351948015)
99. Tadehara F, Yamamoto H, Tsujiyama S, Hinoi T, Matsuo S, Matsumoto N et al. Feasibility of a rapid protocol of 1-day single-isotope rest/adenosine stress Tc-99m sestamibi ECG-gated myocardial perfusion imaging. J Nucl Cardiol 2008; 15(1):35-41. (Pubitemid 351168519)
100. Hida S, Chikamori T, Tanaka H, Igarashi Y, Hatano T, Usui Y et al. Diagnostic value of left ventricular function after adenosine triphosphate loading and at rest in the detection of multivessel coronary artery disease using myocardial perfusion imaging. J Nucl Cardiol 2009; 16(1):20-7.
101. Wu MC, Chin KC, Lin KH, Chiu NT. Diagnostic efficacy of a low-dose 32-projection SPECT 99mTc-sestamibi myocardial perfusion imaging protocol in routine practice. Nucl Med Commun 2009; 30(2):140-7.
102. Yoon AJ, Melduni RM, Duncan SA, Ostfeld RJ, Travin MI. The effect of beta-blockers on the diagnostic accuracy of vasodilator pharmacologic SPECT myocardial perfusion imaging. J Nucl Cardiol 2009; 16(3):358-67.
103. Wolak A, Slomka PJ, Fish MB, Lorenzo S, Berman DS, Germano G. Quantitative diagnostic performance of myocardial perfusion SPECT with attenuation correction in women. J Nucl Med 2008; 49(6):915-22. (Pubitemid 351793432)
104. Wolak A, Slomka PJ, Fish MB, Lorenzo S, Acampa W, Berman DS et al. Quantitative myocardial-perfusion SPECT: comparison of three state-of-the-art software packages. J Nucl Cardiol 2008; 15(1):27-34. (Pubitemid 351168512)
105. Chammas E, Yatim A, Hage C, Sokhn K, Tarcha W, Ghanem G. Evaluation of Tc-99m tetrofosmin scan for coronary artery disease diagnosis. Asian Cardiovasc Thorac Ann 2002; 10(3):244-7.
106. Goodman, C. Literature searching and evidence interpretation for assessing health care practices. Stockholm, Sweden: Swedish Council on Technology Assessment in Health Care. 1996 SBU Report No. 119E.
107. Thompson RC, Cullom SJ. Issues regarding radiation dosage of cardiac nuclear and radiography procedures. J Nucl Cardiol 2006; 13(1):19-23.
108. U.S.Food and Drug Administration. What are the radiation risks from CT? [Internet]. [updated 2009 Jun 8; cited 2009 Dec 14]. Available from: http://www.fda.gov/RadiationEmittingProducts/ RadiationEmittingProductsandProcedures/MedicalImaging/MedicalXRays/ucm115329.htm
109. National Research Council. Health risks from exposure to low levels of ionizing radiation: Beir VII phase 2. Washington, D.C.: The National Academies Press; 2006.
110. Scottish Intercollegiate Guidelines Network. Management of stable angina. A national clinical guideline. [Internet]. [updated 2007; cited 2009 Oct 28]. Available from: http://www.guideline.gov/summary/summary.aspx?ss=15&doc-id= 10584
111. Fraker TD, Jr., Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 2007; 50(23):2264-74.
112. Ontario Case Costing Initiative. Costing analysis tool (CAT) [Internet]. [updated 2009; cited 2009 Nov 18]. Available from: http://www.occp.com/
113. Ontario Ministry of Health and Long-Term Care. Ontario health insurance schedule of benefits and fees [Internet]. [updated 2009; cited 2009 Nov 24]. Available from: http://www.health.gov.on.ca/english/providers/program/ohip/sob/ sob-mn.html
114. Hayashino Y, Shimbo T, Tsujii S, Ishii H, Kondo H, Nakamura T et al. Cost-effectiveness of coronary artery disease screening in asymptomatic patients with type 2 diabetes and other atherogenic risk factors in Japan: factors influencing on international application of evidence-based guidelines. Int J Cardiol 2007; 118(1):88-96. (Pubitemid 46522539)
115. Kreisz FP, Merlin T, Moss J, Atherton J, Hiller JE, Gericke CA. The pre-test risk stratified cost-effectiveness of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease in patients otherwise referred to invasive coronary angiography. Heart, Lung & Circulation 2009; 18(3):200-7.
116. Ladapo JA, Hoffmann U, Bamberg F, Nagurney JT, Cutler DM, Weinstein MC et al. Cost-effectiveness of coronary MDCT in the triage of patients with acute chest pain. AJR American journal of roentgenology 2008; 191(2):455-63.
117. Lorenzoni R, Cortigiani L, Magnani M, Desideri A, Bigi R, Manes C et al. Cost-effectiveness analysis of noninvasive strategies to evaluate patients with chest pain. J Am Soc Echocardiogr 2003; 16(12):1287-91.
118. Maddahi J, Gambhir SS. Cost-effective selection of patients for coronary angiography. J Nucl Cardiol 1997; 4(2):S141-S151.
119. Medical, Advisory Secretariat. Positron emission tomography for the assessment of myocardial viability. Toronto: Ontario Ministry of Health and Long-Term Care. 2005
120. Moir S, Shaw L, Haluska B, Jenkins C, Marwick TH. Left ventricular opacification for the diagnosis of coronary artery disease with stress echocardiography: an angiographic study of incremental benefit and cost-effectiveness. Am Heart J 2007; 154(3):510-8.
121. Paterson DI, Schwartzman K. Strategies incorporating spiral CT for the diagnosis of acute pulmonary embolism: a cost-effectiveness analysis. Chest 2001; 119(6):1791-800.
122. Shaw LJ, Monaghan MJ, Nihoyannopolous P. Clinical and economic outcomes assessment with myocardial contrast echocardiography. Heart 1999; 82 Suppl 3:III16-III21.
123. Wyrick JJ, Kalvaitis S, McConnell KJ, Rinkevich D, Kaul S, Wei K. Cost-efficiency of myocardial contrast echocardiography in patients presenting to the emergency department with chest pain of suspected cardiac origin and a nondiagnostic electrocardiogram. Am J Cardiol 2008; 102(6):649-52.
124. Yong Y, Wu D, Fernandes V, Kopelen HA, Shimoni S, Nagueh SF et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 2002; 89(6):711-8.
125. Bedetti G, Pasanisi EM, Pizzi C, Turchetti G, Lore C. Economic analysis including long-term risks and costs of alternative diagnostic strategies to evaluate patients with chest pain. Cardiovasc Ultrasound 2008; 6:21.
126. Dewey M, Hamm B. Cost effectiveness of coronary angiography and calcium scoring using CT and stress MRI for diagnosis of coronary artery disease. Eur Radiol 2007; 17(5):1301-9.
127. Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999; 130(9):719-28.
128. Hayashino Y, Nagata-Kobayashi S, Morimoto T, Maeda K, Shimbo T, Fukui T. Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors. J Gen Intern Med 2004; 19(12):1181-91. (Pubitemid 40041382)
129. Hernandez R, Vale L. The value of myocardial perfusion scintigraphy in the diagnosis and management of angina and myocardial infarction: a probabilistic economic analysis. Med Decis Making 2007; 27(6):772-88. (Pubitemid 350147815)
130. Khare RK, Courtney DM, Powell ES, Venkatesh AK, Lee TA. Sixty-four-slice computed tomography of the coronary arteries: cost-effectiveness analysis of patients presenting to the emergency department with low-risk chest pain. Acad Emerg Med 2008; 15(7):623-32.
131. Kuntz KM, Fleischmann KE, Hunink MG, Douglas PS. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med 1999; 130(9):709-18.
132. Lee DS, Jang MJ, Cheon GJ, Chung JK, Lee MC. Comparison of the cost-effectiveness of stress myocardial SPECT and stress echocardiography in suspected coronary artery disease considering the prognostic value of false-negative results. J Nucl Cardiol 2002; 9(5):515-22.
133. Rumberger JA, Behrenbeck T, Breen JF, Sheedy PF. Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: a model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods. J Am Coll Cardiol 1999; 33(2):453-62. (Pubitemid 29234208)
134. Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K et al. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technology Assessment (Winchester, England) 2007; 11(49):iii-iv-ix-115.
135. Shaw LJ, Marwick TH, Berman DS, Sawada S, Heller GV, Vasey C et al. Incremental cost-effectiveness of exercise echocardiography vs. SPECT imaging for the evaluation of stable chest pain. Eur Heart J 2006; 27(20):2448-58.
136. Tardif JC, Dore A, Chan KL, Fagan S, Honos G, Marcotte F et al. Economic impact of contrast stress echocardiography on the diagnosis and initial treatment of patients with suspected coronary artery disease. J Am Soc Echocardiogr 2002; 15(11):1335-45. (Pubitemid 36519684)
137. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003; 41(1):159-68.
138. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Jr. et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007; 116(7):e148-e304.
139. Toronto Health Economics and Technology Assessment Collaborative. The relative costeffectiveness of five non-invasive cardiac imaging technologies for diagnosing coronary artery disease in Ontario. Toronto: THETA. 2010 [cited: 2010 Mar 9]. 61 p. Available from: http://theta.utoronto.ca/reports/?id=7